Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Diabetes Care
Jorge Calles-EscandónBruce Hamilton

Abstract

To determine if baseline subgroups in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial can be identified for whom intensive compared with standard glycemia treatment had different effects on all-cause mortality. Exploratory post hoc intention-to-treat comparisons were made between intensive and standard glycemia groups on all-cause mortality by subgroups defined by baseline characteristics. There were few significant interactions between baseline characteristics and effects of intensive versus standard glycemia treatment on mortality: self-reported history of neuropathy (hazard ratio [HR] 1.95, 95% CI 1.41-2.69) versus no history of neuropathy (0.99, 0.79-1.26; P value for interaction 0.0008), higher A1C (A1C >8.5%: HR 1.64, 95% CI 1.22-2.22; A1C 7.5-8.4%: 1.00, 0.75-1.34; A1C <7.5%: 1.00, 0.67-1.50; P value for interaction 0.04), and aspirin use (HR 1.45, 95% CI 1.13-1.85, compared with 0.96, 0.72-1.27, in nonusers; P value for interaction 0.03). We found a remarkable similarity of effect from intensive compared with standard glycemia treatment on mortality across most baseline subgroups. No differential effect was found in subgroups defined by variables anticipated to have an interaction: age, duration of ...Continue Reading

References

Apr 1, 1992·Kidney International·E M DamsgaardC E Mogensen
Dec 1, 1995·Diabetes Care·D K Andersson, K Svärdsudd
Jul 1, 1997·Diabetes Research and Clinical Practice·L A LaveryS C Walker
Mar 1, 2005·Diabetes Care·Michael CusickUNKNOWN Early Treatment Diabetc Retinopathy Study Research Group
Jul 12, 2007·The American Journal of Cardiology·UNKNOWN ACCORD Study GroupMark D Sullivan
Nov 23, 2007·The New England Journal of Medicine·Rui WangJeffrey M Drazen
May 21, 2008·Current Cardiology Reports·Steven E Nissen
May 23, 2008·International Journal of Cardiology·Caroline SiroisJean-Pierre Grégoire
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jun 10, 2008·The New England Journal of Medicine·Robert G Dluhy, Graham T McMahon
Nov 11, 2008·JAMA : the Journal of the American Medical Association·Hisao OgawaUNKNOWN Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Jan 6, 2009·Diabetes Care·UNKNOWN American Diabetes Association
Apr 16, 2009·JAMA : the Journal of the American Medical Association·Lawrence H YoungUNKNOWN DIAD Investigators
Apr 22, 2009·Annals of Internal Medicine·Victor M Montori, Mercè Fernández-Balsells

❮ Previous
Next ❯

Citations

Apr 3, 2012·Current Diabetes Reports·Preeti KishoreJill P Crandall
Mar 4, 2011·The New England Journal of Medicine·Hertzel C GersteinWilliam T Friedewald
Dec 24, 2010·Diabetes Technology & Therapeutics·Eran BashanIsrael Hodish
Jul 13, 2011·Experimental Diabetes Research·Christina VoulgariChristodoulos Stefanadis
May 20, 2011·The Journal of Clinical Endocrinology and Metabolism·Jane E B Reusch, Cecilia C Low Wang
Mar 24, 2011·Sports Medicine·Ben F HurleyAndrew K Sheaff
Jun 13, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Morten CharlesSimon J Griffin
Jun 26, 2014·Journal of Diabetes and Metabolic Disorders·Filipe Prazeres, Daniela Figueiredo
Aug 21, 2014·Current Diabetes Reports·Lynn AngRodica Pop-Busui
Apr 28, 2011·Current Opinion in Endocrinology, Diabetes, and Obesity·Matthew C Riddle
May 16, 2014·Canadian Journal of Diabetes·S Ali ImranStuart Ross
Oct 25, 2012·The American Journal of Cardiology·Saifullah Nasir, David Aguilar
Oct 25, 2012·The American Journal of Cardiology·Cecilia C Low Wang, Jane E B Reusch
Dec 15, 2015·European Journal of Heart Failure·Douglas H J ElderChim C Lang
May 12, 2012·Endocrinology and Metabolism Clinics of North America·Matthew C Riddle, Kevin C J Yuen
Nov 8, 2011·Journal of Diabetes and Its Complications·William C DuckworthUNKNOWN Investigators of the VADT
May 30, 2013·Journal of Diabetes·Zachary Bloomgarden
May 3, 2016·Journal of Diabetes and Its Complications·Mark Stecker, Matthew Stevenson
Jun 28, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·M TavakoliR A Malik
Feb 8, 2013·Annals of the New York Academy of Sciences·Francesco GiorginoLuigi Laviola
Aug 3, 2011·The Journal of Clinical Hypertension·Yehuda Handelsman, Paul S Jellinger
Dec 23, 2011·Journal of the American Geriatrics Society·Hsin-Chieh YehFrederick L Brancati
Apr 4, 2013·Journal of Diabetes Investigation·Aaron I VinikCarolina M Casellini
Oct 7, 2010·Journal of Diabetes·Zachary Bloomgarden, Yehuda Handelsman
May 21, 2014·Journal of Diabetes·Zachary T Bloomgarden
Apr 14, 2016·Reviews in Endocrine & Metabolic Disorders·Jana EngelmannUlrike Rothe
Jun 18, 2011·Postgraduate Medicine·Thomas Blevins
Jul 6, 2015·Heart Failure Clinics·Justin M Vader, Michael W Rich
Apr 23, 2015·Current Diabetes Reports·Michelle KakuDavid M Simpson
Dec 24, 2013·Journal of Diabetes and Its Complications·April P CarsonAlethea N Hill

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.